What We Do

We produce the research and analysis that institutions need to make informed decisions in women's health. This includes market landscape mapping, risk and cost audits, evidence synthesis, and regulatory pathway analysis.

Our work translates fragmented clinical evidence into structured intelligence, identifying where hidden costs are buried, where care pathways break down, and where the highest-impact opportunities sit.

Ongoing strategic partnership for organizations navigating the women's health economy. We work alongside leadership teams to shape product strategy, clinical integration, commercial positioning, and stakeholder engagement.

Our network spans payers, pharma, health systems, investors, and policy, built over years of convening across Davos, Basel, Zurich, London, and New York. We connect the right people to accelerate execution.

ORI is our applied intelligence layer, built to translate female-specific medical evidence into real-world clinical and economic decision-making. It uses AI-driven personalization and structured clinical logic to guide care pathways, surface hidden risk cohorts, and generate interpretable data for modeling and policy.

For organizations, ORI means moving from generic population health to sex-specific precision, identifying where members, patients, or employees are falling through the cracks and what to do about it.